Dynamics of papillomavirus in vivo disease formation & susceptibility to high-level disinfection—Implications for transmission in clinical settings
Open Access
- 6 January 2021
- journal article
- research article
- Published by Elsevier BV in EBioMedicine
- Vol. 63, 103177
- https://doi.org/10.1016/j.ebiom.2020.103177
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Council
This publication has 34 references indexed in Scilit:
- E4 Antibodies Facilitate Detection and Type-Assignment of Active HPV Infection in Cervical DiseasePLOS ONE, 2012
- Human Papillomavirus Vaccines – Immune ResponsesVaccine, 2012
- Differentiation-Dependent Interpentameric Disulfide Bond Stabilizes Native Human Papillomavirus Type 16PLOS ONE, 2011
- Sterility of Reusable Transrectal Ultrasound Transducer Assemblies for Prostate Biopsy Reprocessed According to Food and Drug Administration Guidelines—Bacteriologic Outcomes in a Clinical SetupUrology, 2011
- Carrageenan Is a Potent Inhibitor of Papillomavirus InfectionPLoS Pathogens, 2006
- Efficient Intracellular Assembly of Papillomaviral VectorsJournal of Virology, 2004
- Normal Growth and Differentiation in a Spontaneously Immortalized Near-Diploid Human Keratinocyte Cell Line, NIKSJournal of Investigative Dermatology, 2000
- Ineffectiveness of Latex Condoms in Preventing Contamination of the Transvaginal Ultrasound Transducer HeadSouthern Medical Journal, 1997
- Comparison of probe sheaths for endovaginal sonographyObstetrics & Gynecology, 1996
- A Rigorous Test for SPARC's Chemical Reactivity Models: Estimation of More Than 4300 Ionization pKasQuantitative Structure-Activity Relationships, 1995